EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indefinite for dysplasia in Barrett’s esophagus carries substantial risk for prevalent and incident neoplasia: updated outcomes and long-term follow-up

Brian E White, Yue Ren, Hongzhe Li, Maureen DeMarshall, Zhaohai Yang, Gary W Falk

Gastrointestinal Endoscopy · 2026

DOI: 10.1016/j.gie.2025.04.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastrointestinal Endoscopy, 2026. Verfasst von Brian E White und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvan…. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma, Precancerous Conditions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Castle Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: The optimal management of patients with Barrett's esophagus (BE) that is indefinite for dysplasia (IND) is unclear because of uncertain risks of progression to low-grade dysplasia (LGD), high-grade dysplasia (HGD), and esophageal adenocarcinoma (EAC). In this study, we aimed to define the risks of neoplasia among patients IND, including long-term follow-up of our previously described cohort, and to identify risk factors for progression to neoplasia. METHODS: Patients IND from 2000 to 2023 were identified from the University of Pennsylvania Health System pathology database and the BE patient registry. Prevalent neoplasia was defined as LGD, HGD, or EAC occurring within 1 year of the index EGD. Incident neoplasia occurred >1 year after the index EGD. Time to neoplasia was analyzed with the Cox proportional hazards regression model. Risk factors for neoplasia were identified using logistic and Cox regression. RESULTS: Of 299 identified patients, 223 had a follow-up EGD within 1 year. Of these 223 patients, 9.87% had prevalent neoplasia of any grade: LGD in 3.14%, HGD in 5.38%, and EAC in 1.35%. Two hundred seventeen patients without prevalent neoplasia had an EGD after 1 year, with a median follow-up of 4.37 years (IQR, 2.62-8.15); 22% developed incident neoplasia. The incidence of any neoplasia was 4.35 per 100 person-years: 2.43 for LGD, 1.24 for HGD, and 0.47 for EAC. BE length and smoking were associated with incident neoplasia (hazard ratio, 1.13 [95% CI, 1.03-1.25] and 2.01 [95% CI, 1.12-3.80], respectively). CONCLUSIONS: IND carries substantial risk for progression to neoplasia including HGD and EAC, especially in the first year after diagnosis. Incident HGD and EAC risk approximates that published for LGD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsAdenocarcinomaPrecancerous ConditionsHumansMaleFemaleMiddle AgedAgedRisk FactorsFollow-Up StudiesIncidencePrevalenceDisease ProgressionProportional Hazards Models

Autor:innen und Institutionen

  • Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Biostatistics and Epidemiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Pathology & Laboratory Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Electronic addre…

Förderung

  • Castle Biosciences

Zitieren

APA

White, B. E., Ren, Y., Li, H., DeMarshall, M., Yang, Z., & Falk, G. W. (2026). Indefinite for dysplasia in Barrett’s esophagus carries substantial risk for prevalent and incident neoplasia: updated outcomes and long-term follow-up. Gastrointestinal Endoscopy. https://doi.org/10.1016/j.gie.2025.04.034

Vancouver

White BE, Ren Y, Li H, DeMarshall M, Yang Z, Falk GW. Indefinite for dysplasia in Barrett’s esophagus carries substantial risk for prevalent and incident neoplasia: updated outcomes and long-term follow-up. Gastrointestinal Endoscopy. 2026. doi:10.1016/j.gie.2025.04.034

BibTeX
@article{White2026,
  author = {White, Brian E and Ren, Yue and Li, Hongzhe and DeMarshall, Maureen and Yang, Zhaohai and Falk, Gary W},
  title = {Indefinite for dysplasia in Barrett’s esophagus carries substantial risk for prevalent and incident neoplasia: updated outcomes and long-term follow-up},
  journal = {Gastrointestinal Endoscopy},
  year = {2026},
  doi = {10.1016/j.gie.2025.04.034}
}
Kostenlos starten →